Medicine and Dentistry
Adaptive Immunity
100%
Advanced Glycation End Product Receptor Antagonist
33%
Atherosclerosis
33%
Biological Marker
33%
Biostatistics
33%
Clinical Trial
66%
Diabetes
33%
Human Subject
33%
Insulin Dependent Diabetes Mellitus
100%
Reperfusion Injury
33%
Serositis
33%
Transgenic Mouse
33%
Pharmacology, Toxicology and Pharmaceutical Science
Advanced Glycation End Product Receptor Antagonist
33%
Atherosclerosis
33%
Biological Marker
33%
Biostatistics
33%
Clinical Trial
66%
Human
33%
Inflammation
100%
Insulin Dependent Diabetes Mellitus
100%
Reperfusion Injury
33%
Transgenic Mouse
33%
Immunology and Microbiology
Adaptive Immune System
100%
Atherosclerosis
50%
Human
50%
Inflammation Response
50%
Reperfusion
50%
Transgenic Mouse
50%